MedTrace Logo

Hemodialysis Reliable Outflow (HeRO) Vascular Access Patency Study

NCT00890045 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2024-01-29

Study results available
· View outcomes & findings →

Summary

Compare the HeRO Vascular Access Device to a conventional ePTFE graft.

Conditions

  • Renal Failure Chronic Requiring Hemodialysis

Interventions

DEVICE

HeRO Vascular Access Device

HeRO Vascular Access Device

DEVICE

Conventional ePTFE hemodialysis graft

Conventional ePTFE hemodialysis graft

Sponsors & Collaborators

  • CryoLife, Inc.

    collaborator INDUSTRY

  • Merit Medical Systems, Inc.

    lead INDUSTRY

Principal Investigators

  • Marc Glickman, MD · Sentara Heart Hospital, Norfolk, VA

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
22 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-07-31
Primary Completion
2008-03-31
Completion
2008-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00890045 on ClinicalTrials.gov